ArticleCardiology and therapy2020

Efficacy and Safety of Ivabradine Once-Daily Prolonged-Release versus Twice-Daily Immediate-Release Formulation in Patients with Stable Chronic Heart Failure with Systolic Dysfunction: A Randomized, Double-Blind, Phase 3 Non-Inferiority (PROFICIENT) Study.

Ajit Mullasari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.